Comparison of the efficacy and safety of Chinese generic imatinib and branded imatinib in patients with chronic myeloid leukemia in consideration of demographic characteristics

被引：0
|
作者：
窦雪琳 [1 ]
机构：
[1] Peking Univ People’s Hosp,Peking Univ Hematol Instit
来源：
China Medical Abstracts(Internal Medicine) | 2020年 / 37卷 / 01期
关键词：
Comparison of the efficacy and safety of Chinese generic imatinib and branded imatinib in patients with chronic myeloid leukemia in consideration of demographic characteristics;
D O I：
暂无
中图分类号：
R733.72 [慢性白血病];
学科分类号：
摘要：
Objective To compare the efficacy and safety of Chinese generic imatinib with branded imatinib as frontline therapy in adults with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP)(Frontline group),and to explore the efficacy and safety of Chinese generic imatinib in CML-CP patients switching from branded imatinib (Switching group).Methods Frontline group:Data of adults with newly diagnosed CML-CP re-
引用
收藏
页码：59 / 60
页数：2
相关论文
共 50 条
  • [21] Hematologic and Molecular Responses to Generic Imatinib in Patients With Chronic Myeloid Leukemia
    Razmkhah, Farnaz
    Razavi, Mohsen
    Zaker, Farhad
    Kazemi, Ahmad
    Negari, Shahin
    Rasighaemi, Parisa
    Kalantarmotamedi, Mojdeh
    Zarei, Mina
    Pazhakh, Vahid
    LABMEDICINE, 2010, 41 (09): : 547 - 550
  • [22] Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study
    Pagnano, Katia B.
    Fava, Carmen
    Miranda, Eliana C.
    Bendit, Israel
    Seguro, Fernanda S.
    Magalhaes, Gustavo H. R.
    Clementino, Nelma D.
    Conchon, Monika
    Goncalves, Natalia N.
    Gaidano, Gianluca
    Lunghi, Monia
    Moellmann-Coelho, Arthur
    Luise, Ingrid
    Bergamaschi, Micaela
    Ferrero, Dario
    Centrone, Renato
    Pregno, Patrizia
    Fogliatto, Laura
    Giai, Valentina
    Dragani, Matteo Emidio
    Moiraghi, Elena
    Bortolini, Jaisson
    Castelli, Andrea
    Cuttica, Alessandra
    Bortolheiro, Teresa Cristina
    Pinna, Cristiane
    De Souza, Carmino Antonio
    Saglio, Giuseppe
    BLOOD, 2018, 132
  • [23] Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest
    Danthala, Madhav
    Gundeti, Sadashivudu
    Kuruva, Siva Prasad
    Puligundla, Krishna Chaitanya
    Adusumilli, Praveen
    Karnam, Ashok Pillai
    Bala, Stalin
    Konatam, Meher Lakshmi
    Maddali, Lakshmi Srinivas
    Digumarti, Raghunadha Rao
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (07): : 457 - 462
  • [24] Clinical efficacy and safety of imatinib in the management of Ph+ chronic myeloid or acute lymphoblastic leukemia in Chinese patients
    Zhu, Yu
    Qian, Si-Xuan
    ONCOTARGETS AND THERAPY, 2014, 7 : 395 - 404
  • [25] Comparing the efficacy of generic Imatinib formulations with the original Imatinib as the frontline tyrosine kinase inhibitor in chronic phase chronic myeloid leukemia
    Demirkan, Fatih
    Sevindik, Omur Gokmen Gokmen
    Karaman, Aysegul
    Alacacioglu, Inci
    Solmaz, Serife Medeni
    Ozsan, Guner Hayri
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia
    Denson, Ariel
    DiSogra, Kristyn Y.
    Arnall, Justin
    Sanikommu, Srinivasa R.
    Shah, Nilay A.
    Ragon, Brittany K.
    Knight, Thomas G.
    Ai, Jing
    Grunwald, Michael R.
    Avalos, Belinda R.
    Copelan, Edward A.
    Chojecki, Aleksander L.
    BLOOD, 2020, 136
  • [27] The Efficacy and Tolerability of Generic of Imatinib in a Very Specific Group of Chronic Myeloid Leukemia (CML)
    Conchon, Monika
    BLOOD, 2015, 126 (23)
  • [28] Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpasa experience
    Eskazan, Ahmet Emre
    Soysal, Teoman
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (02) : 382 - 384
  • [29] Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population
    Yanmin Zhao
    Lizhen Liu
    Yingjia Wang
    Gongqiang Wu
    Xiaoyu Lai
    Weijie Cao
    Yi Luo
    Yamin Tan
    Jimin Shi
    Wanzhuo Xie
    Xiujin Ye
    Zhen Cai
    Maofang Lin
    He Huang
    International Journal of Hematology, 2009, 89 : 445 - 451
  • [30] Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemia
    Wang, Qing
    Jiang, Zhi-Ping
    Yu, Er-Qian
    Zeng, Jing
    Zhu, Yan
    Cai, Hua-Lin
    Yan, Miao
    Xiang, Da-Xiong
    Zhao, Xie-Lan
    Xu, Ping
    Jiao, Zheng
    Hoan Linh
    PHARMACOGENOMICS, 2019, 20 (04) : 251 - 260
12345